Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U4 small nuclear 33, pseudogene (RNU4-33P)** is a pseudogene of a small nuclear RNA (snRNA) gene. Like other snRNA pseudogenes, RNU4-33P is classified as a non-coding RNA and does not produce a functional RNA or protein product. It is not believed to have a biological role in spliceosomal activity, unlike functional U4 snRNAs, and currently has no known clinical significance or therapeutic targeting applications[1]. **Additional context:** - The term “pseudogene” indicates this locus is a non-functional copy or fragment of a gene that may resemble a protein- or RNA-coding gene but is not itself functional[1]. - No evidence supports RNU4-33P as a protein, enzyme, receptor, transporter, or therapeutic target. This sharply contrasts with functional copies like RNU4-2, which are implicated in splicing and neurodevelopmental disease[3][4]. **Interpretation:** - RNU4-33P is best classified as a non-target pseudogene, with no current biological or therapeutic relevance. - The entry is likely **not a relevant therapeutic target** and may be listed by mistake in databases or target lists.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 33, pseudogene (RNU4-33P).